NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%
NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%

ICICI Securities Maintains Buy Rating on SBI Life Insurance

SBI Life Insurance Company has demonstrated resilience in the face of multiple challenges, achieving mid-teen growth with a healthy VNB margin of 26-28% as per its guidance. This achievement is a testament to the company's robust business model, which has enabled it to maintain its market position despite the difficulties it has faced.

The company's FY26 performance was marked by a core operating RoEV of approximately 19%, as well as higher growth in non-banca channels. Specifically, the banca, agency, and other channels reported year-over-year growth of 11%, 15.2%, and 21.9% in FY26, respectively. SBI Life's product mix also showed signs of improvement, with retail protection and annuity growing by 24% and 34% in FY26, respectively.

A comparison of SBI Life's product mix to its peers reveals a traditionally high ULIP and low protection mix, with ULIP and protection products accounting for 59.4% and 9.2% of its total APE, respectively, as of FY26. However, the company has made notable progress in improving its product mix, which is expected to have a positive impact on its overall performance.

Read also: Markets Continue Downward Trend as Nifty Drops Below 24,200 and Sensex Falls 852 Points

SBI Life's track record is also noteworthy, with APE, VNB, and EV CAGR of 15.3%, 21.8%, and 20.5%, respectively, over the period of FY20-25. Additionally, the company's valuation remains attractive, with a P/EV of 1.7x FY28E. Based on these factors, ICICI Securities maintains its constructive outlook on SBI Life Insurance.

RecommendationFY27E APE GrowthFY28E APE GrowthVNB Margin FY27EVNB Margin FY28E
ICICI Securities15%15%28%28.5%

As a result, ICICI Securities is maintaining its BUY rating on SBI Life Insurance with a revised target price of INR 2,345, based on a 2.1x FY28E EV multiple.

Investor Takeaway

Investors should consider retaining a BUY rating for SBI Life Insurance Company with a revised target price of INR 2,345.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.